Dr. Haffizulla: Dr. Anderson, we’re here at the San Antonio Breast Cancer Conference. Can you share with our viewership any major topics that you’d like to highlight?
Dr. Anderson: Well, there’s been a lot of interesting studies here, progress is being made. I’m really excited about the systemic therapy changes that are taking place. I’m a surgeon, and so, actually for me and my colleagues, what I’m seeing that’s really interesting is this increasing focus on de-escalation, really the question of how do we do less? And it’s easy to do more, it’s easy to do bigger things and more extensive things, but that’s actually not what the patient needs, what we want to do is decrease the trauma and at the same time is improving outcome, and not decreasing outcomes and having worsened findings. So, in surgery, we’re looking at how do we do less surgery, how do we find situations where after our surgery there can be less radiotherapy or more focused or shorter-term radiotherapy, and are there situations that we don’t need to operate? This is really a big question. We think both about the breast and the lymph nodes. We’re moving away from doing complete axillary node dissections, but the big question is, is there a point that’s too much? If you really have a lot of tumor in the nodes, that may well be an area where the systemic therapy and radiotherapy’s not enough, and so we’re trying to figure that out in ways that are most effective.